{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:40:23Z","timestamp":1777956023691,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06656-2","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:52:27Z","timestamp":1774511547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute megakaryoblastic leukemia with myeloid sarcoma among a pediatric patient harbouring RBM15::MRTFA: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiao-qing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-pei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dun-hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-yin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"6656_CR1","doi-asserted-by":"crossref","unstructured":"A study by Dastugue et al. (2002) on the cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7) was conducted by the Groupe Francais de Cytogenetique Hematologique (GFCH). This research is supported by additional studies that highlight the clinical and cytogenetic characteristics of AMKL, such as the poor prognosis and the importance of early diagnosis, as well as the impact of Down syndrome on survival rates.","DOI":"10.1182\/blood-2001-12-0241"},{"key":"6656_CR2","doi-asserted-by":"crossref","unstructured":"Athale UH et al. explored the clinical and biological characteristics of childhood acute megakaryoblastic leukemia (AMKL), highlighting the importance of early diagnosis and the impact on prognosis. Studies indicate that AMKL, characterized by abnormal proliferation of megakaryoblasts, presents with symptoms such as fever, hemorrhage, and hepatosplenomegaly. Diagnostic techniques like bone marrow smears and immunophenotyping are crucial for accurate diagnosis, with CD41+CD61+ immunophenotype being indicative of the disease. The prognosis for AMKL is generally poor, with a high rate of misdiagnosis and complex clinical and biological features. Childhood acute megakaryoblastic leukemia: a single institution's experience. Blood. 2001;97(12):3727\u201332.","DOI":"10.1182\/blood.V97.12.3727"},{"issue":"8","key":"6656_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00277-015-2383-2","volume":"94","author":"J Schweitzer","year":"2015","unstructured":"Schweitzer J, Zimmermann M, Rasche M, von Neuhoff C, Creutzig U, Dworzak M, et al. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML - BFM 04 trial. Ann Hematol. 2015;94(8):1327\u201336. https:\/\/doi.org\/10.1007\/s00277-015-2383-2.","journal-title":"Ann Hematol"},{"issue":"5","key":"6656_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/17474086.2019.1609351","volume":"12","author":"F De Marchi","year":"2019","unstructured":"De Marchi F, Araki M, Komatsu N. Molecular clinical features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia. Expert Rev Hematol. 2019;12(5):285\u201393.","journal-title":"Expert Rev Hematol"},{"issue":"13","key":"6656_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1182\/blood-2015-02-629204","volume":"126","author":"H Inaba","year":"2015","unstructured":"Inaba H, Zhou Y, Abla O, Adachi S, Auvrignon A, Beverloo HB, et al. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. Blood. 2015;126(13):1575\u201384.","journal-title":"Blood"},{"key":"6656_CR6","doi-asserted-by":"crossref","unstructured":"de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Berna Beverloo H, Baruchel A, Trka J, NUP98\/JARID1A fusion has been identified as a recurrent genetic abnormality in pediatric acute megakaryoblastic leukemia (AMKL), characterized by a unique HOX gene expression pattern. This abnormality is significant as it contributes to the distinct clinical and biological features of AMKL, as evidenced by clinical studies and genetic analyses. Leukemia. 2013;27(12):2280\u20138.","DOI":"10.1038\/leu.2013.87"},{"key":"6656_CR7","unstructured":"de Rooij JD et al. have contributed to the understanding of recurrent acute megakaryoblastic leukemia (AMKL), a subtype of acute myeloid leukemia characterized by the proliferation of abnormal megakaryocytes. Genetic abnormalities, such as the CBFA2T3-GLIS2 fusion gene, can be utilized for risk stratification in pediatric AMKL, as demonstrated in a retrospective intergroup study. Blood. 2016;127(26):3424\u201330."},{"issue":"5","key":"6656_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/pbc.22765","volume":"56","author":"L Torres","year":"2011","unstructured":"Torres L, Lisboa S, Vieira J, Cerveira N, Santos J, Pinheiro M, et al. Acute megakaryoblastic leukemia with a four-way variant translocation that originates the RBM15-MKL1 fusion gene. Pediatr Blood Cancer. 2011;56(5):846\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"6656_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4274\/tjh.2013.0189","volume":"32","author":"M G\u00f6k\u00e7e","year":"2015","unstructured":"G\u00f6k\u00e7e M, Ayta\u00e7 S, \u00dcnal \u015e, Altan \u0130, G\u00fcmr\u00fck F, \u00c7etin M. Acute megakaryoblastic leukemia with t(1;22) mimicking neuroblastoma in an infant. Turk J Hematol. 2015;32(1):64\u20137. https:\/\/doi.org\/10.4274\/tjh.2013.0189.","journal-title":"Turk J Hematol"},{"issue":"3","key":"6656_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28111","volume":"67","author":"ML Marques-Piubelli","year":"2020","unstructured":"Marques-Piubelli ML, Cordeiro MG, Cristofani L, Barroso RS, Paes VR, Castelli JB, et al. Acute megakaryoblastic leukemia with t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an infant: the role of karyotype in differential diagnosis. Pediatr Blood Cancer. 2020;67(3):e28111.","journal-title":"Pediatr Blood Cancer"},{"key":"6656_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.875510","volume":"10","author":"M Guti\u00e9rrez-Jimeno","year":"2022","unstructured":"Guti\u00e9rrez-Jimeno M, Panizo-Morgado E, Calvo-Imirizaldu M, Gal\u00e1n-G\u00f3mez V, Escudero-L\u00f3pez A, Pati\u00f1o-Garc\u00eda A. Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation. Front Pediatr. 2022;10:875510. https:\/\/doi.org\/10.3389\/fped.2022.875510.","journal-title":"Front Pediatr"},{"issue":"2","key":"6656_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00428-024-03766-z","volume":"486","author":"F G\u00fcndo\u011fdu","year":"2025","unstructured":"G\u00fcndo\u011fdu F, Agaimy A, Ayta\u00e7 S, Hazar V, \u00dcner A, K\u00f6semehmeto\u011flu K. Myeloid sarcoma with RBM15::MRTFA (MKL1) mimicking vascular neoplasm. Virchows Arch. 2025;486(2):405\u201310. https:\/\/doi.org\/10.1007\/s00428-024-03766-z.","journal-title":"Virchows Arch"},{"key":"6656_CR13","unstructured":"The WHO Classification of Tumours Editorial Board has released a beta version of the Haematolymphoid Tumours classification, which includes a comprehensive list of haematological and lymphoid neoplasms, such as myeloproliferative neoplasms, lymphomas, and mast cell diseases, with detailed descriptions of their morphological, immunophenotypic, genetic, and clinical features. IARC Press; 2022. Accessed October 30, 2022."},{"issue":"1","key":"6656_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/sj.leu.2401639","volume":"14","author":"J Bernstein","year":"2000","unstructured":"Bernstein J, Dastugue N, Haas OA, Harbott J, Heerema NA, Huret JL, et al. A study group report on nineteen cases of t(1;22)(p13;q13) acute megakaryoblastic leukemia in infants\/children, supplemented by a review of thirty-nine cases, highlights the clinical and cytogenetic characteristics of this rare subtype of leukemia. Leukemia. 2000;14(1):216\u20138.","journal-title":"Leukemia"},{"key":"6656_CR15","doi-asserted-by":"publisher","unstructured":"Ramia de Cap M, Chen W. Myeloid sarcoma, a rare malignant tumor, originates from the bone marrow and other tissues, characterized by its high invasiveness and tendency to metastasize. The World Health Organization (WHO) has classified it as a specific entity within the category of acute myeloid leukemia, referring to masses composed of myeloid precursor or immature myeloid cells formed outside the bone marrow. Historical descriptions date back to 1811, with the tumor being named 'green tumor' or chloroma due to its green appearance caused by myeloperoxidase in the tissue. Over time, the understanding of the tumor has evolved, leading to the current designation of 'myeloid sarcoma' by the WHO in 2001. Semin Diagn Pathol. 2023;40(3):129\u2013139. https:\/\/doi.org\/10.1053\/j.semdp.2023.04.009.","DOI":"10.1053\/j.semdp.2023.04.009"},{"issue":"3","key":"6656_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","volume":"132","author":"C Campidelli","year":"2009","unstructured":"Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132(3):426\u201337. https:\/\/doi.org\/10.1309\/AJCP1ZA7HYZKAZHS.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"6656_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5114\/wo.2016.65602","volume":"20","author":"M Samborska","year":"2016","unstructured":"Samborska M, Derwich K, Skalska-Sadowska J, Kurzawa P, Wachowiak J. Myeloid sarcoma in children - diagnostic and therapeutic difficulties. Contemp Oncol (Pozn). 2016;20(6):444\u20138. https:\/\/doi.org\/10.5114\/wo.2016.65602.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"6","key":"6656_CR18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.7534\/j.issn.1009-2137.2017.06.009","volume":"25","author":"HC Cheng","year":"2017","unstructured":"Cheng HC, Liu SW, Liu Y, Zhao XF, Li W, Qiu L, et al. [Application of Next Generation Sequencing for AML\/MDS Diagnosis and Treatment]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017;25(6):1631\u20135. https:\/\/doi.org\/10.7534\/j.issn.1009-2137.2017.06.009. Chinese.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"23","key":"6656_CR19","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.3390\/curroncol30060395","volume":"30","author":"F Guijarro","year":"2023","unstructured":"Guijarro F, Garrote M, Villamor N, Colomer D, Esteve J, L\u00f3pez - Guerra M. Novel tools for diagnosis and monitoring of AML. Curr Oncol. 2023;30(23):5201\u201313. https:\/\/doi.org\/10.3390\/curroncol30060395.","journal-title":"Curr Oncol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06656-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06656-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06656-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:45:38Z","timestamp":1777941938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06656-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6656"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06656-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to Declaration of Helsinki principles and approved by the Institutional Review Board of Sun Yat-sen Memorial Hospital(SY\u00a0SEC2-2025-BA-1238), and the informed consent forms were signed by the guardians of the patients involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent forms were signed by the guardians of the patients involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}